key: cord-0931670-jq1op87o authors: Aponte-Serrano, Josua O.; Weaver, Jordan J.A.; Sego, T.J.; Glazier, James A.; Shoemaker, Jason E. title: Multicellular Spatial Model of RNA Virus Replication and Interferon Responses Reveals Factors Controlling Plaque Growth Dynamics date: 2021-03-16 journal: bioRxiv DOI: 10.1101/2021.03.16.435618 sha: afbec26a5cdf60962de2faad5464a72152c1c8fc doc_id: 931670 cord_uid: jq1op87o Respiratory viruses present major health challenges, as evidenced by the 2009 influenza pandemic and the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Severe RNA virus respiratory infections often correlate with high viral load and excessive inflammation. Understanding the dynamics of the innate immune response and its manifestation at the cell and tissue levels are vital to understanding the mechanisms of immunopathology and developing improved, strain independent treatments. Here, we present a novel spatialized multicellular spatial computational model of two principal components of tissue infection and response: RNA virus replication and type-I interferon mediated antiviral response to infection within lung epithelial cells. The model is parameterized using data from influenza virus infected cell cultures and, consistent with experimental observations, exhibits either linear radial growth of viral plaques or arrested plaque growth depending on the local concentration of type I interferons. Modulating the phosphorylation of STAT or altering the ratio of the diffusion constants of interferon and virus in the cell culture could lead to plaque growth arrest. The dependence of arrest on diffusion constants highlights the importance of developing validated spatial models of cytokine signaling and the need for in vitro experiments to measure these diffusion constants. Sensitivity analyses were performed under conditions creating both continuous plaque growth and arrested plaque growth. Findings suggest that plaque growth and cytokine assay measurements should be collected during arrested plaque growth, as the model parameters are significantly more sensitive and more likely to be identifiable. The model’s metrics replicate experimental immunostaining imaging and titer based sampling assays. The model is easy to extend to include SARS-CoV-2-specific mechanisms as they are discovered or to include as a component linking epithelial cell signaling to systemic immune models. Author Summary COVID-19 is possibly the defining healthcare crisis of the current generation, with tens of millions of global cases and more than a million reported deaths. Respiratory lung infections form lesions in the lungs, whose number and size correlate with severity of illness. In some severe cases, the disease triggers a severe inflammatory condition known as cytokine storm. Given the complexity of the immune system, computational modeling is needed to link molecular signaling at the site of inflection to the signaling impact on the overall immune system, ultimately revealing how severe inflammatory conditions may emerge. Here, we created a computational model of the early stages of infection that simulates lung cells infected with RNA viruses, such those responsible for COVID-19 and influenza, to help explore how the disease forms viral plaques, an in vitro analog to lesion growth in the lung. Our model recapitulates in vitro observations that pretreatment of biological signaling molecules called with type-I interferons, which are currently being evaluated for treatment of COVID-19. Analyzing the model, we, can stop viral plaque growth. We found that enhancing certain aspects of the innate immune system, such as the JAK/STAT pathway, may be able to stop viral plaque growth, suggesting molecules involved in this pathway as possible drug candidates. Quantifying the parameters needed to model interferon signaling and viral replication, experiments should be performed under conditions that inhibit viral growth, such as pretreating cells with interferon. We present a computational framework that is essential to constructing larger models of respiratory infection induced immune responses, can be used to evaluate drugs and other medical interventions quickly, cheaply, and without the need for animal testing during the initial phase, and that defines experiments needed to improve our fundamental understanding of the mechanisms regulating the immune response. 208 plaque arrest versus uncontained growth) are deterministic. We averaged plaque growth metrics for 209 sensitivity analyses over 20 simulations (S1 Text Fig 6) . In experiments, plaque-plaque interference occurs when two or more plaques grow into the same spatial region, slowing the radial growth of all plaques 211 involved. This paper simulates only growth of isolated plaques. local concentration field which cells are exposed to. Note that differences arise due to a discrete number of 239 cells rather than a normalized population value, from the stochasticity associated with cell transitions (Eq. The model distinguishes eclipse phase (I1) and virus releasing (I2) cells, which is not normally seen in 277 experimental plaque growth assays. Seeding the simulation with a single initially infected cell, Fig 4C 278 shows that the multicellular spatial model replicates these experimental observations. A lag phase during 279 which the initially transfected virus is establishing its replication and export is seen both experimentally 280 (Fig 4A,B ) and in the simulation (Fig 4C) . Fig 4D- simulations (S1 Text Fig 6) . Greater viral inhibition of RIG-I signaling via nonstructural protein production often increases viral 337 infection severity (41-43). We investigated the effects of varying the antagonistic strength on plaque growth 338 dynamics in silico. In all simulations thus far, RIG-I is assumed to be fully antagonized by the invading 339 virus (k 11 = 0). We ran single plaque simulations with 0%, 25%, 50%, 75%, and 100% RIG-I activity relative 340 to the value in an NS1 knockout training simulation using A/Puerto Rico/8/1934 (dNS1PR8) . At 80 hours 341 post infection (Fig 6A) plaque radius is nearly unchanged in all cases. However, the cell type composition 342 (Fig 6B) changes significantly. Higher levels of RIG-I signaling (larger values of 11 ) lead to less cell death 343 (Fig 6C) , lower viral titer (Fig 6D) , and much greater interferon production ( Fig 6E) . We explored increased interferon diffusion constants, which emulate different media types in vitro (22) replicates. If the average growth rate was 0 we classified the parameters as leading to plaque arrest, 388 otherwise we classified the parameters as leading to continued growth (blue). In our simulations an 389 interferon diffusion constant of about 8-to 10-fold times the viral diffusion constant led to plaque growth 390 arrest (Fig 8) . We have explored the spatiotemporal behavior of a multicellular spatial model of the cellular innate immune 437 response to viral infection. To do so, we developed a general approach to adapting an existing ODE model 438 of spatially homogenized dynamics to create a calibrated spatiotemporal model, which has the potential to 439 enable the addition of spatial investigations to many existing ODE frameworks in systems biology. One of the striking takeaways is the bifurcation between plaques growing without limit and plaque arrest. This insight into the bifurcation between uncontained plaque growth and plaque arrest would be impossible 442 without a spatial aspect present in the model and can be readily understood as a metric of disease 443 progression and severity. We demonstrated plaque arrest under elevated interferon diffusion (Fig 8) , 444 elevated paracrine signaling (Fig 5) , and interferon prestimulation (Fig 7) . Lethal Dissemination 521 of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling 522 in a Mouse Model of Infection Innate immune responses to influenza A H5N1: 525 friend or foe? Trends Immunol Toll-like receptor pre-528 stimulation protects mice against lethal infection with highly pathogenic influenza viruses Type I 531 interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV SARS-CoV-2 is sensitive 534 to type I interferon pretreatment Immune response 537 modeling of interferon beta-pretreated influenza virus-infected human dendritic cells Interferon-α2b Treatment for 541 COVID-19. Front Immunol Validated models of immune response to virus infection Dynamics of 563 Influenza Virus Infection and Pathology A dynamical model of human immune response to influenza 566 A virus infection Multi-Scale Modeling 568 of Tissues Using CompuCell3D In Vitro Studies with Modoc Virus in Vero Cells: Plaque Assay and Kinetics 571 of Growth, Neutralization, and Thermal Inactivation Enumeration of bacteriophages 573 by double agar overlay plaque assay Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B 576 viruses A Simple Plaque Inhibition Test for Antiviral Agents: Application to Assay of 579 Interferon Antitrinitrophenyl (TNP) Plaque Assay. Primary Response of Balb/c Mice 581 to Soluble and Particupre Immunogen Studies on vaccinia virus plaque formation and its inhibition by 585 interferon. III. A simplified plaque inhibition assay of interferon Plaque inhibition assay for drug susceptibility testing of 588 influenza viruses Mathematical Modeling of RNA Virus Sensing Pathways Reveals 591 Paracrine Signaling as the Primary Factor Regulating Excessive Cytokine Production. Processes 592 Influenza A virus infection kinetics: Quantitative data and models 595 Wiley Interdisciplinary Reviews: Systems Biology and Medicine. NIH Public 596 Access SnapShot: Pathways of Antiviral Innate Immunity Influenza A Virus Cell Entry, Replication, Virion 602 Assembly and Movement. Front Immunol [Internet] SARS coronavirus and innate immunity IFN? induction by influenza 607 A virus is mediated by RIG-I which is regulated by the viral NS1 protein RIG-I and TLR3 are both required 611 for maximum interferon induction by influenza virus in human lung alveolar epithelial cells Triggering antiviral response by RIG-I-614 related RNA helicases Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 CoV-2 is a potent pathogenicity factor 1 redirecting host protein synthesis machinery toward viral 627 Interferon activation and innate immunity Functional classification of 633 interferon-stimulated genes identified using microarrays Interferon-stimulated genes: a complex web of host 637 defenses A physical and regulatory 640 map of host-influenza interactions reveals pathways in H1N1 infection Time and length scales of autocrine 644 signals in three dimensions Database for mRNA half-life 646 of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse 647 embryonic stem cells Regulation of IRF7 through cell type-specific protein stability Correlation between cell enlargement and nucleic acid and protein 651 content of hela cells in unbalanced growth produced by inhibitors of DNA synthesis Systems-wide proteomic 655 analysis in mammalian cells reveals conserved, functional protein turnover Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection. Cell 659 Andrographolide inhibits influenza A virus-induced 662 inflammation in a murine model through NF-κB and JAK-STAT signaling pathway. Microbes 663 Infect Blocking of the Alpha Interferon-Induced Jak-Stat Signaling 665 Pathway by Japanese Encephalitis Virus Infection Different roles for human lung dendritic 668 cell subsets in pulmonary immune defense mechanisms Antiviral activities of type I interferons 674 to SARS-CoV-2 infection Innate antiviral responses by means of 677 TLR7-mediated recognition of single-stranded RNA Supporting Information Captions 681 S1 Text. Supporting Information Figures In vivo, virus and IFN don't diffuse passively, due to cilia action, periciliary fluid, and mucosal layer driven 459 advection. We will explore these active transport mechanisms in future work. Elevating STATP activity, as affected by k 31 and explored in Fig 5,